David A. Wrone

1.6k total citations
25 papers, 1.1k citations indexed

About

David A. Wrone is a scholar working on Dermatology, Oncology and Epidemiology. According to data from OpenAlex, David A. Wrone has authored 25 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Dermatology, 6 papers in Oncology and 5 papers in Epidemiology. Recurrent topics in David A. Wrone's work include Cancer and Skin Lesions (5 papers), Dermatologic Treatments and Research (4 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). David A. Wrone is often cited by papers focused on Cancer and Skin Lesions (5 papers), Dermatologic Treatments and Research (4 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). David A. Wrone collaborates with scholars based in United States, Vietnam and Philippines. David A. Wrone's co-authors include Murad Alam, Jeffrey S. Dover, Kenneth A. Arndt, William Posten, Sirunya Silapunt, Ronald L. Moy, Gregg M. Menaker, Murad Alam, Arash Kimyai‐Asadi and Te‐Shao Hsu and has published in prestigious journals such as JAMA, Journal of the American Academy of Dermatology and Lasers in Surgery and Medicine.

In The Last Decade

David A. Wrone

25 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David A. Wrone United States 12 596 535 191 151 118 25 1.1k
Sirunya Silapunt United States 21 657 1.1× 914 1.7× 454 2.4× 256 1.7× 302 2.6× 84 1.8k
Mario A. Trelles France 21 387 0.6× 840 1.6× 62 0.3× 82 0.5× 334 2.8× 90 1.2k
Won‐Serk Kim South Korea 21 315 0.5× 785 1.5× 159 0.8× 106 0.7× 327 2.8× 97 1.7k
Jason R. Lupton United States 18 278 0.5× 1.0k 2.0× 110 0.6× 57 0.4× 328 2.8× 31 1.3k
Sung Bin Cho South Korea 22 261 0.4× 1.1k 2.0× 163 0.9× 74 0.5× 189 1.6× 132 1.6k
Richard A. Eiferman United States 23 679 1.1× 113 0.2× 127 0.7× 65 0.4× 176 1.5× 64 1.5k
Macrene Alexiades‐Armenakas United States 22 223 0.4× 1.3k 2.4× 262 1.4× 46 0.3× 323 2.7× 47 1.6k
Joop M. Grevelink United States 19 332 0.6× 1.0k 1.9× 84 0.4× 131 0.9× 198 1.7× 32 1.2k
Elizabeth L. Tanzi United States 24 541 0.9× 2.3k 4.3× 234 1.2× 93 0.6× 654 5.5× 58 2.6k
Roy C. Grekin United States 20 82 0.1× 766 1.4× 393 2.1× 362 2.4× 510 4.3× 62 1.5k

Countries citing papers authored by David A. Wrone

Since Specialization
Citations

This map shows the geographic impact of David A. Wrone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Wrone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Wrone more than expected).

Fields of papers citing papers by David A. Wrone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Wrone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Wrone. The network helps show where David A. Wrone may publish in the future.

Co-authorship network of co-authors of David A. Wrone

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Wrone. A scholar is included among the top collaborators of David A. Wrone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Wrone. David A. Wrone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Jack, Jason Cohen, David A. Wrone, & Alejandro A. Gru. (2021). Primary cutaneous follicle center lymphoma with aberrant CD8 expression. Journal of Cutaneous Pathology. 49(4). 403–407. 1 indexed citations
2.
Wrone, David A.. (2012). Clinical Dermatology: A Color Guide to Diagnosis and Therapy. JAMA. 307(14). 1534–1534. 12 indexed citations
3.
Wrone, David A.. (2010). Body Rejuvenation. JAMA. 304(17). 1958–1958. 1 indexed citations
4.
Alam, Murad, D Barzilai, & David A. Wrone. (2006). Power and Sample Size of Therapeutic Trials in Procedural Dermatology: How Many Patients Are Enough?. Dermatologic Surgery. 31(2). 201–205. 7 indexed citations
5.
Alam, Murad, Simon Yoo, David A. Wrone, Lucile E. White, & John Y. S. Kim. (2006). Sterility assessment of multiple use botulinum A exotoxin vials: A prospective simulation. Journal of the American Academy of Dermatology. 55(2). 272–275. 26 indexed citations
6.
Alam, Murad, D Barzilai, & David A. Wrone. (2006). Confidence Intervals in Procedural Dermatology: An Intuitive Approach to Interpreting Data. Dermatologic Surgery. 31(4). 462–466. 2 indexed citations
7.
Posten, William, David A. Wrone, Jeffrey S. Dover, et al.. (2006). Low-Level Laser Therapy for Wound Healing: Mechanism and Efficacy. Dermatologic Surgery. 31(3). 334–340. 362 indexed citations
8.
Alam, Murad, William Posten, Mary C. Martini, David A. Wrone, & Alfred Rademaker. (2006). Aesthetic and Functional Efficacy of Subcuticular Running Epidermal Closures of the Trunk and Extremity. Archives of Dermatology. 142(10). 1272–8. 19 indexed citations
9.
Posten, William, David A. Wrone, Jeffrey S. Dover, et al.. (2005). Low-Level Laser Therapy for Wound Healing. Dermatologic Surgery. 31(3). 334–340. 218 indexed citations
10.
Wrone, David A., et al.. (2004). The development of actinic keratosis into invasive squamous cell carcinoma: Evidence and evolving classification schemes. Clinics in Dermatology. 22(3). 189–196. 89 indexed citations
11.
Wrone, David A., et al.. (2004). The Expression of p63 in Actinic Keratoses, Seborrheic Keratosis, and Cutaneous Squamous Cell Carcinomas. Dermatologic Surgery. 30(10). 1299–1302. 34 indexed citations
12.
Alam, Murad, Te‐Shao Hsu, Jeffrey S. Dover, David A. Wrone, & Kenneth A. Arndt. (2003). Nonablative laser and light treatments: Histology and tissue effects—A Review. Lasers in Surgery and Medicine. 33(1). 30–39. 87 indexed citations
13.
Wrone, David A., et al.. (2003). Cutaneous surgery in the elderly: ensuring comfort and safety. Dermatologic Therapy. 16(3). 243–253. 6 indexed citations
14.
Zembowicz, Artur, et al.. (2003). Linear ectodermal cutaneous hamartoma. International Journal of Dermatology. 42(5). 376–379. 5 indexed citations
15.
Warner, Thomas F., David A. Wrone, Eliot C. Williams, et al.. (2002). Heparan Sulphate Proteoglycan in Scleromyxedema Promote FGF-2 Activity. Pathology - Research and Practice. 198(10). 701–707. 6 indexed citations
16.
Wrone, David A., et al.. (2001). Andrews' Diseases of the Skin: Clinical Dermatology, 9th ed. Archives of Dermatology. 137(4). 518–518. 11 indexed citations
17.
Wrone, David A., Kenneth K. Tanabe, A. Benedict Cosimi, et al.. (2000). Lymphedema After Sentinel Lymph Node Biopsy for Cutaneous Melanoma. Archives of Dermatology. 136(4). 511–4. 43 indexed citations
18.
Wrone, David A., et al.. (2000). Hidradenitis Suppurativa Polyposa. Pathology - Research and Practice. 196(8). 589–592. 8 indexed citations
19.
Menaker, Gregg M., et al.. (1999). Treatment of Facial Rhytids with a Nonablative Laser: A Clinical and Histologic Study. Dermatologic Surgery. 25(6). 440–444. 155 indexed citations
20.
Wrone, David A., Susan M. Swetter, Barbara M. Egbert, Bruce R. Smoller, & Paul A. Khavari. (1996). Increased proportion of aggressive-growth basal cell carcinoma in the Veterans Affairs population of Palo Alto, California. Journal of the American Academy of Dermatology. 35(6). 907–910. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026